Denis Schrier, PhD
About Denis Schrier, PhD
Denis Schrier, PhD, serves as the Vice President of Toxicology at Inozyme Pharma, where he has worked since 2018. With over 40 years of experience in toxicology and drug development, he has held leadership roles at several pharmaceutical companies, including Pfizer, Stryker Regenerative Medicine, and Alexion Pharmaceuticals.
Current Role at Inozyme
Denis Schrier serves as the Vice President of Toxicology at Inozyme Pharma, a position he has held since 2018. In this role, he focuses on the toxicological evaluation of drug candidates, contributing to the development of innovative therapies for rare connective tissue disorders. His leadership is instrumental in guiding the toxicology strategy and ensuring compliance with regulatory standards in drug development. Schrier's extensive experience in the pharmaceutical industry aids in advancing Inozyme's mission to address unmet medical needs.
Previous Experience at Alexion Pharmaceuticals
Prior to joining Inozyme Pharma, Denis Schrier worked at Alexion Pharmaceuticals as the Executive Director of Non-Clinical Pharma/Toxicology from 2012 to 2016. During his tenure in Cambridge, MA, he played a key role in overseeing non-clinical toxicology studies and contributed to the development of therapies aimed at rare diseases. His experience at Alexion further solidified his expertise in toxicology and drug safety assessments.
Career at Pfizer R&D
Denis Schrier spent over two decades at Pfizer R&D, where he held various leadership roles from 1982 to 2005. He served as a Senior Research Fellow and Director, focusing on toxicology and preclinical development. His long tenure at Pfizer allowed him to gain extensive knowledge in drug development processes and toxicological evaluations, shaping his career in the pharmaceutical industry.
Educational Background
Denis Schrier earned his PhD in Pathology from the Medical College of Wisconsin, where he studied from 1977 to 1980. He also holds a Bachelor of Arts in Biology from Calvin College, which he completed from 1973 to 1977. His academic background in pathology and biology provides a strong foundation for his extensive career in toxicology and drug development.
Expertise in Toxicology and Drug Development
With over 40 years of experience in toxicology and drug development, Denis Schrier has developed a strong background in both pathology and biology. His expertise encompasses various aspects of toxicology, including preclinical development and regulatory compliance. Throughout his career, he has worked in leadership roles across multiple pharmaceutical companies, contributing to the advancement of new drug therapies.